IP Watchdog

AUGUST 7, 2022

recently in Novartis Pharmaceuticals Corp. Accord Healthcare Inc. But in Novartis Pharmaceuticals v. Accord Healthcare, neither of the panel members in the majority of the original opinion even agreed to rehear the case, let alone agreed to reverse their prior ruling. Talk about snatching victory from the jaws of defeat!

Pharmaceuticals 78

Pharmaceuticals Healthcare Litigation 78

InHouseBlog

APRIL 8, 2022

VP, Litigation & Employment Law , www.princetonlegal.com (Princeton, NJ). Senior Director, Compliance Risk Navigation , Regeneron Pharmaceuticals (Tarrytown, NY). Regulatory Litigation Attorney , Southern California Edison (Hybrid Remote). Director, IP Litigation , Inscripta, Inc. Legal Counsel , TuneIn (Remote).

Real Estate 97

Real Estate Pharmaceuticals Litigation Technology 97

IP Watchdog

AUGUST 12, 2024

Supreme Court’s reasoning in Helsinn Healthcare v. Teva Pharmaceuticals (2019), the Federal Circuit rejected Celanese’s contentions that statutory changes wrought by the America Invents Act (AIA) altered the on-sale bar such that sales of products manufactured by an undisclosed process would not invalidate patents claiming that process.

Pharmaceuticals 64

Pharmaceuticals Healthcare Manufacturing Technology 64

IP Watchdog

JUNE 21, 2022

Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Accord Healthcare, Inc. Earlier today, the U.S. granting a petition for rehearing from appellant HEC Pharm Co.,

Expert Testimony 59

Expert Testimony Pharmaceuticals Healthcare Evidence 59

Complex Discovery

MARCH 12, 2025

Healthcare and Pharma Consolidation: With regulatory shifts and technological advancements in biotech, pharmaceutical mergers are increasing, driven by both innovation and cost-saving incentives. Poor governance can also lead to litigation risks if sensitive data is mismanaged. The solution?

Technology 52

Technology Pharmaceuticals Litigation Healthcare 52

IP Watchdog

MAY 3, 2022

On April 29, the United States Court of Appeals for the Federal Circuit (CAFC) affirmed in part, reversed in part, vacated in part, and remanded a decision of the United States District Court for the Northern District of Illinois regarding alleged infringement by U.S. Venture Inc., Sunoco).

Counterclaim 116

Counterclaim Construction Healthcare Pharmaceuticals 116

Complex Discovery

NOVEMBER 3, 2024

Such capabilities are essential for addressing the challenges of cross-border litigation and vast data volumes, ensuring higher efficiency and accuracy. UnitedLex appointed Renee Meisel as its new CEO, signaling a shift toward bolstered leadership aimed at driving innovation across its litigation and compliance offerings.

Government and Public Sector 69

Government and Public Sector Technology Cross-Examination Energy and Utilities 69